AAAAAA

   
Results: 1-18 |
Results: 18
STUDIES ON THE MOLECULAR MECHANISM OF GROWTH-INHIBITION WITH P53 ADENOVIRAL CONSTRUCT IN HUMAN OVARIAN-CANCER
Authors: MUJOO K CATINO JJ MANEVAL DC GUTTERMAN JU
Citation: K. Mujoo et al., STUDIES ON THE MOLECULAR MECHANISM OF GROWTH-INHIBITION WITH P53 ADENOVIRAL CONSTRUCT IN HUMAN OVARIAN-CANCER, International journal of gynecological cancer, 8(3), 1998, pp. 233-241
P202 SELF-ASSOCIATES THROUGH A SEQUENCE CONSERVED AMONG THE MEMBERS OF THE 200-FAMILY PROTEINS
Authors: KOUL D OBEYESEKERE NU GUTTERMAN JU MILLS GB CHOUBEY D
Citation: D. Koul et al., P202 SELF-ASSOCIATES THROUGH A SEQUENCE CONSERVED AMONG THE MEMBERS OF THE 200-FAMILY PROTEINS, FEBS letters, 438(1-2), 1998, pp. 21-24
P202 PREVENTS APOPTOSIS IN MURINE AKR-2B FIBROBLASTS
Authors: KOUL D LAPUSHIN R XU HJ MILLS GB GUTTERMAN JU CHOUBEY D
Citation: D. Koul et al., P202 PREVENTS APOPTOSIS IN MURINE AKR-2B FIBROBLASTS, Biochemical and biophysical research communications, 247(2), 1998, pp. 379-382
CLINICAL INVESTIGATORS - THE DRIVING-FORCE BEHIND DRUG DISCOVERY
Authors: GUTTERMAN JU
Citation: Ju. Gutterman, CLINICAL INVESTIGATORS - THE DRIVING-FORCE BEHIND DRUG DISCOVERY, Nature biotechnology, 15(7), 1997, pp. 598-599
A PHASE-I STUDY OF TNP-470 ADMINISTERED TO PATIENTS WITH ADVANCED SQUAMOUS-CELL CANCER OF THE CERVIX
Authors: KUDELKA AP LEVY T VERSCHRAEGEN CF EDWARDS CL PIAMSOMBOON S TERMRUNGRUANGLERT W FREEDMAN RS KAPLAN AL KIEBACK DG MEYERS CA JAECKLE KA LOYER E STEGER M MANTE R MAVLIGIT G KILLIAN A TANG RA GUTTERMAN JU KAVANAGH JJ
Citation: Ap. Kudelka et al., A PHASE-I STUDY OF TNP-470 ADMINISTERED TO PATIENTS WITH ADVANCED SQUAMOUS-CELL CANCER OF THE CERVIX, Clinical cancer research, 3(9), 1997, pp. 1501-1505
RECREATING AN ENVIRONMENT FOR CLINICAL DISCOVERY
Authors: GUTTERMAN JU
Citation: Ju. Gutterman, RECREATING AN ENVIRONMENT FOR CLINICAL DISCOVERY, Clinical cancer research, 3(12), 1997, pp. 2594-2597
INHIBITION OF E2F-4 DP-1-STIMULATED TRANSCRIPTION BY P202/
Authors: CHOUBEY D GUTTERMAN JU
Citation: D. Choubey et Ju. Gutterman, INHIBITION OF E2F-4 DP-1-STIMULATED TRANSCRIPTION BY P202/, Oncogene, 15(3), 1997, pp. 291-301
INTERFERON-ALPHA-INDUCED HUMAN LUPUS INCLUSIONS AND P36 PROTEIN IN CANCER AND AIDS
Authors: VAKHARIA DD SZEBENYI SE GUTTERMAN JU RICH SA
Citation: Dd. Vakharia et al., INTERFERON-ALPHA-INDUCED HUMAN LUPUS INCLUSIONS AND P36 PROTEIN IN CANCER AND AIDS, Journal of interferon & cytokine research, 16(9), 1996, pp. 709-715
ADENOVIRAL-MEDIATED P53 TUMOR-SUPPRESSOR GENE-THERAPY OF HUMAN OVARIAN-CARCINOMA
Authors: MUJOO K MANEVAL DC ANDERSON SC GUTTERMAN JU
Citation: K. Mujoo et al., ADENOVIRAL-MEDIATED P53 TUMOR-SUPPRESSOR GENE-THERAPY OF HUMAN OVARIAN-CARCINOMA, Oncogene, 12(8), 1996, pp. 1617-1623
INHIBITION OF E2F-MEDIATED TRANSCRIPTION BY P202
Authors: CHOUBEY D LI SJ DATTA B GUTTERMAN JU LENGYEL P
Citation: D. Choubey et al., INHIBITION OF E2F-MEDIATED TRANSCRIPTION BY P202, EMBO journal, 15(20), 1996, pp. 5668-5678
THE INTERFERON-INDUCIBLE GROWTH-INHIBITORY P202 PROTEIN - DNA-BINDINGPROPERTIES AND IDENTIFICATION OF A DNA-BINDING DOMAIN
Authors: CHOUBEY D GUTTERMAN JU
Citation: D. Choubey et Ju. Gutterman, THE INTERFERON-INDUCIBLE GROWTH-INHIBITORY P202 PROTEIN - DNA-BINDINGPROPERTIES AND IDENTIFICATION OF A DNA-BINDING DOMAIN, Biochemical and biophysical research communications, 221(2), 1996, pp. 396-401
RECOMBINANT HUMAN RETINOBLASTOMA PROTEIN INHIBITS CANCER CELL-GROWTH
Authors: PAGLIARO LC ANTELMAN D JOHNSON DE MACHEMER T MCCULLOCH EA FREIREICH EJ STASS SA SHEPARD HM MANEVAL D GUTTERMAN JU
Citation: Lc. Pagliaro et al., RECOMBINANT HUMAN RETINOBLASTOMA PROTEIN INHIBITS CANCER CELL-GROWTH, Cell growth & differentiation, 6(6), 1995, pp. 673-680
THE LASKER-AWARDS AT 50
Authors: DEBAKER ME GUTTERMAN JU
Citation: Me. Debaker et Ju. Gutterman, THE LASKER-AWARDS AT 50, JAMA, the journal of the American Medical Association, 274(13), 1995, pp. 1061-1061
CYTOKINE THERAPEUTICS - LESSONS FROM INTERFERON-ALPHA
Authors: GUTTERMAN JU
Citation: Ju. Gutterman, CYTOKINE THERAPEUTICS - LESSONS FROM INTERFERON-ALPHA, Proceedings of the National Academy of Sciences of the United Statesof America, 91(4), 1994, pp. 1198-1205
A PHASE-I CLINICAL-STUDY OF LOW-DOSE ORAL INTERFERON-ALPHA
Authors: DHINGRA K DUVIC M HYMES S MCLAUGHLIN P ROTHBERG J GUTTERMAN JU
Citation: K. Dhingra et al., A PHASE-I CLINICAL-STUDY OF LOW-DOSE ORAL INTERFERON-ALPHA, Journal of immunotherapy with emphasis on tumor immunology, 14(1), 1993, pp. 51-55
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS A CAUSE OF PARANEOPLASTIC LEUKEMOID REACTION IN ADVANCED TRANSITIONAL-CELL CARCINOMA
Authors: WETZLER M ESTROV Z TALPAZ M MARKOWITZ A GUTTERMAN JU KURZROCK R
Citation: M. Wetzler et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS A CAUSE OF PARANEOPLASTIC LEUKEMOID REACTION IN ADVANCED TRANSITIONAL-CELL CARCINOMA, Journal of internal medicine, 234(4), 1993, pp. 417-420
UBIQUITOUS EXPRESSION OF CYTOKINES IN DIVERSE LEUKEMIAS OF LYMPHOID AND MYELOID LINEAGE
Authors: KURZROCK R KANTARJIAN H WETZLER M ESTROV Z ESTEY E TROUTMANWORDEN K GUTTERMAN JU TALPAZ M
Citation: R. Kurzrock et al., UBIQUITOUS EXPRESSION OF CYTOKINES IN DIVERSE LEUKEMIAS OF LYMPHOID AND MYELOID LINEAGE, Experimental hematology, 21(1), 1993, pp. 80-85
EFFECT OF RECOMBINANT HUMAN RETINOBLASTOMA PROTEIN ON AML BLASTS
Authors: PAGLIARO LC MCCULLOCH EA STASS SA FREIREICH EJ WEN SF WIDEMAN J GUTTERMAN JU
Citation: Lc. Pagliaro et al., EFFECT OF RECOMBINANT HUMAN RETINOBLASTOMA PROTEIN ON AML BLASTS, Blood, 82(10), 1993, pp. 10000544-10000544
Risultati: 1-18 |